Verorab®

BIOLOGICAL4 trials

Sponsors

Sinovac Biotech Co., Ltd, European Vaccine Initiative

Conditions

Malaria FeverRabiesRabies (Healthy Volunteers)

Phase 1

A Challenge Study to Assess the Blood-stage Efficacy of Full-length SUM-101 Malaria Vaccine Candidate

WithdrawnNCT07124156

European Vaccine InitiativeMalaria Fever

Start: 2026-03-20End: 2026-12-31Updated: 2026-09-11

Phase 2

Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)

Not yet recruitingNCT07055880

Sinovac Biotech Co., LtdRabies

Start: 2025-07-28End: 2026-01-15Target: 120Updated: 2025-07-09

Phase 3

Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen

Not yet recruitingNCT07055295

Sinovac Biotech Co., LtdRabies

Start: 2026-03-01End: 2026-12-30Target: 390Updated: 2025-07-08

Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen

Not yet recruitingNCT07055893

Sinovac Biotech Co., LtdRabies (Healthy Volunteers)

Start: 2026-03-01End: 2027-01-30Target: 390Updated: 2025-07-09